Expertise in
1
conditions

Dr. Michael Joyce

Family Medicine
MultiCare Covington Medical Center
17700 SE 272nd St, 
Covington, WA 
Clinical Trials:Currently Recruiting for 2 Trials
Expertise in
1
conditions
MultiCare Covington Medical Center
17700 SE 272nd St, 
Covington, WA 

Overview

Michael Joyce is a primary care provider, practicing in Family Medicine in Covington, Washington.

Dr. Joyce is highly rated in 1 condition, according to our data. His clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Cyclic Vomiting Syndrome, and Infantile Neutropenia.

He is actively involved in clinical research, co-authoring 25 peer reviewed articles and participating in 6 clinical trials.

Specialties

Family Medicine

Licenses

Family Medicine in WA

Hospital Affiliations

Multicare Auburn Medical Center
Valley Medical Center
Tacoma General Allenmore Hospital
Multicare Covington Medical Center
Multicare Good Samaritan Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Coordinated Care
  • HMO
  • MANAGED MEDICAID PLAN
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

MultiCare Covington Medical Center
17700 SE 272nd St, Covington, WA 98042
Other Locations
Allina Health System
701 Dellwood St S, Cambridge, MN 55008

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications
Enrollment Status: Recruiting
Publish Date: June 04, 2026
Intervention Type: Drug
A Multicenter Safety Study of Unlicensed, Investigational Cryopreserved Cord Blood Units Manufactured by the National Cord Blood Program and Provided for Unrelated Hematopoietic Stem Cell Transplantation of Pediatric and Adult Patients
A Multicenter Safety Study of Unlicensed, Investigational Cryopreserved Cord Blood Units Manufactured by the National Cord Blood Program and Provided for Unrelated Hematopoietic Stem Cell Transplantation of Pediatric and Adult Patients
Enrollment Status: Recruiting
Publish Date: April 13, 2026
Intervention Type: Biological
Study Phase: Phase 2
Applying Biomarkers to Long-term Effects in Child and Adolescent Cancer Treatment (ABLE Team) - Predictive Biomarkers For Pediatric Chronic Graft-Versus-Host Disease
Applying Biomarkers to Long-term Effects in Child and Adolescent Cancer Treatment (ABLE Team) - Predictive Biomarkers For Pediatric Chronic Graft-Versus-Host Disease
Enrollment Status: Unknown
Publish Date: December 05, 2023
A Phase I Trial of Dose Escalation of Metformin in Combination With Vincristine, Irinotecan, and Temozolomide in Children With Relapsed or Refractory Solid Tumors
A Phase I Trial of Dose Escalation of Metformin in Combination With Vincristine, Irinotecan, and Temozolomide in Children With Relapsed or Refractory Solid Tumors
Enrollment Status: Completed
Publish Date: January 13, 2023
Intervention Type: Drug
Study Drugs: Vincristine, Irinotecan, Temozolomide, Metformin
Study Phase: Phase 1
A Single-arm, Prospective Study of Remestemcel-L, Ex-vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD
A Single-arm, Prospective Study of Remestemcel-L, Ex-vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD
Enrollment Status: Completed
Publish Date: March 17, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Study of Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute TReaTment of MigrAiNe: A Randomized, Double-blind, Placebo-controlled Parallel Group Study (SPARTAN)
A Study of Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute TReaTment of MigrAiNe: A Randomized, Double-blind, Placebo-controlled Parallel Group Study (SPARTAN)
Enrollment Status: Completed
Publish Date: September 23, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

25 Total Publications

Beyond Predators: Carnivores as Secondary Dispersers of Mycorrhizal Fungi.
Beyond Predators: Carnivores as Secondary Dispersers of Mycorrhizal Fungi.
Journal: Ecology letters
Published: July 09, 2025
Similar Doctors
Expertise in
8
conditions
Dr. Peter Taylor
Family Medicine
Expertise in
8
conditions
Dr. Peter Taylor
Family Medicine

Family Practice Associates Of Olympia PLLC

3525 Ensign Rd NE Ste R, 
Olympia, WA 
 (36.7 miles away)
360-459-3663
Languages Spoken:
English
See accepted insurances

Peter Taylor is a primary care provider, practicing in Family Medicine in Olympia, Washington. Dr. Taylor is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Arthritis, Psoriatic Arthritis, Necrosis, Psoriasis, and Tissue Biopsy.

Expertise in
33
conditions
Dr. David R. Kennel
Family Medicine
Expertise in
33
conditions
Dr. David R. Kennel
Family Medicine

Physician Care NW

5920 100th Street SW, # 31, 
Lakewood, WA 
 (21.3 miles away)
253-584-3023
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

David Kennel is a primary care provider, practicing in Family Medicine in Lakewood, Washington. Dr. Kennel is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Xanthoma, Familial Combined Hyperlipidemia, Cirrhosis, and High Cholesterol. Dr. Kennel is board certified in Family Medicine. Dr. Kennel is currently accepting new patients.

Expertise in
2
conditions
Dr. Carla Greenbaum
Family Medicine
Expertise in
2
conditions
Dr. Carla Greenbaum
Family Medicine

UwMc-Roosevelt

4245 Roosevelt Way NE, 
Seattle, WA 
 (13.9 miles away)
206-598-4882
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Carla Greenbaum is a Family Medicine provider practicing medicine in Seattle, Washington. Dr. Greenbaum is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Diabetic Ketoacidosis, and Low Blood Sugar.

Frequently Asked Questions about Dr. Michael Joyce

How do I make an appointment with Dr. Michael Joyce?

You can book an appointment with Dr. Michael Joyce by calling their office at 253-372-6500. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Michael Joyce a top-rated expert for Chronic Graft Versus Host Disease (cGvHD)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michael Joyce is classified as an Advanced expert for Chronic Graft Versus Host Disease (cGvHD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Michael Joyce specialize in?

While Dr. Michael Joyce is a Family Medicine, they have specific expertise in Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), and Cyclic Vomiting Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Family Medicine.

Does Dr. Michael Joyce participate in research or clinical trials?

Yes. Dr. Michael Joyce has published 25 articles and abstracts on conditions like Chronic Graft Versus Host Disease (cGvHD). You can view a list of Dr. Michael Joyce's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Michael Joyce accept my insurance?

Dr. Michael Joyce accepts most major insurance plans, including Coordinated Care and Humana. We recommend calling the office directly at 253-372-6500 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Joyce's expertise for a condition
ConditionClose
      View All 26 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile